Establishment of a pharmaceutical plant to produce oncological medicines

The promoter of the company is in the business of whole-sale trading of pharmaceuticals, agro-produce with both domestic and export markets. The promoters established the present company in 2021 to engage in the manufacturing of pharmaceutical products both for the domestic and foreign market. The project is established with the objective of manufacturing pharmaceutical products with a special focus on oncological products (anti-cancer products). The project is expected to produce 47 types of oncology (anti-cancer) medication it’s targeted to sell its product both in domestic and export markets primarily in Kenya, Sudan, Uganda, and Tanzania. The proposed project is expected to cost USD 49 million and is financed by both the owner 20% and the rest 80 % will be covered by a bank loan. According to the feasibility study conducted, the project will have NPV of USD 13,195,733 and pay pack period of 3.14 years . Currently, the project construction is going ahead with the promoter’s equity. To enter the production phase on the pre-specified date the promoter has highly interested to get foreign business with minority stake in the company.

High